AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Anticholinergic adjunct therapy for gastric cancers

Summary

This technology is a method for treating gastric cancers by inhibiting the cholinergic receptors that could be combined with existing chemotherapies for an improved treatment regimen.

Technology Benefits

Readily-available and well-tolerated May increase the effectiveness of current standard-of-care therapies Inexpensive and currently FDA-approved anticholinergic drugs will have minimal effects on cost of treatment

Technology Application

Adjuvant treatment for patients with gastric cancer undergoing chemo- and/or radiotherapyPre-symptomatic treatment for patients at high risk of developing gastric cancerNeoadjuvant (pre-surgical) treatment for patients with resectable gastric tumorsAlternative therapy for gastric cancer in place of invasive surgeryResearch tool for examining the molecular biology and cellular pathogenesis of gastric cancerResearch tool for investigating effects of neurotransmitters, innervation, and cholinergic blockade on cancer

Detailed Technology Description

None

Country/Region

USA

For more information, please click Here